SCHEMBL116772

SCHEMBL116772

CC(C)[Si](Oc1ccc(C(CCNC(=O)O)C(=O)Nc2cc3ccncc3cc2C(C)(C)C)cc1)(C(C)C)C(C)C

nearest known ligand 0.42

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 19/20 0.42
TRPV1 Q8NER1 1/20 0.37
ROCK1 Q13464 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL115845 0.84 ROCK2 (0.58) ROCK2ROCK1
SCHEMBL116265 0.83 ROCK2 (0.45) ROCK2ROCK1
SCHEMBL2777034 0.77 ROCK2 (0.54) ROCK2ROCK1
SCHEMBL111744 0.77 ROCK2 (0.60) ROCK2ROCK1
SCHEMBL117418 0.77 ROCK2 (0.44) ROCK2ROCK1
SCHEMBL21359235 0.72 ROCK2 (0.52) ROCK2ROCK1
SCHEMBL2775048 0.72 ROCK2 (0.56) ROCK2ROCK1
SCHEMBL113916 0.70 ROCK2 (0.78) ROCK2ROCK1
SCHEMBL112543 0.69 ROCK2 (0.72) ROCK2ROCK1
SCHEMBL2775044 0.68 ROCK2 (0.56) ROCK2ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424857-A1 DUAL-ACTION INHIBITORS AND METHODS OF USING SAME Aerie Pharmaceuticals, Inc. (US) 2012-03-07 EP disclosed
WO-2010127329-A1 DUAL-ACTION INHIBITORS AND METHODS OF USING SAME AERIE PHARMACEUTICALS, INC. (US) 2010-11-04 WO disclosed
WO-2010127330-A1 DUAL-ACTION INHIBITORS AND METHODS OF USING SAME AERIE PHAMACEUTICALS, INC. (US) 2010-11-04 WO disclosed